Granahan Investment Management - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 170 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$7,550,000
+4.0%
731,558
+6.0%
0.14%
-8.4%
Q1 2021$7,263,000
-6.6%
690,410
+37.4%
0.15%
-12.0%
Q4 2020$7,779,000
+99.1%
502,542
+87.7%
0.18%
+31.6%
Q3 2020$3,908,000
-52.9%
267,697
-38.9%
0.13%
-55.7%
Q2 2020$8,297,000438,0810.30%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Delphi Management Partners VIII, L.L.C. 2,263,006$35,031,00023.03%
Palo Alto Investors LP 5,267,652$81,543,0004.28%
Fairmount Funds Management LLC 702,351$10,872,0003.89%
Birchview Capital, LP 188,000$2,910,0001.68%
Mesirow Financial Investment Management, Inc. 22,303$345,250,0001.09%
EMERALD ADVISERS, LLC 1,822,781$28,217,0000.94%
EMERALD MUTUAL FUND ADVISERS TRUST 1,661,236$25,716,0000.90%
RICE HALL JAMES & ASSOCIATES, LLC 1,552,504$24,033,0000.85%
Altium Capital Management LP 133,951$2,074,0000.77%
Hood River Capital Management LLC 931,754$14,424,0000.48%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders